PSS14 WHAT COST OF HLA-B5801 GENOTYPING WOULD BE COST EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND- ANALYSES USING A DECISION-ANALYTIC MODEL
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73373-3
https://www.valueinhealthjournal.com/article/S1098-3015(11)73373-3/fulltext
Title :
PSS14 WHAT COST OF HLA-B5801 GENOTYPING WOULD BE COST EFECTIVE FOR THE PREVENTION OF ALLOPURINOL-INDUCED STEVENS JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS IN THAILAND- ANALYSES USING A DECISION-ANALYTIC MODEL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73373-3&doi=10.1016/S1098-3015(11)73373-3
First page :
A564
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
1532